RSV Infection: Clinical Trials

3 trials for RSV Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1

Follow RSV Infection: new trials by email Literature Review of RSV Infection trials Research Report on RSV Infection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSVpreF, Placebo - RSV Infection
Phase 3RecruitingPfizer5502025-04-162026-10-14
Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
Clesrovimab, Palivizumab, Placebo - RSV Infection
Phase 3CompletedMerck Sharp & Dohme LLC10032021-11-302026-05-08
Effect of Heliox on RSV Bronchiolitis
Heliox, Air - RSV Infection, Acute Bronchiolitis
Phase 3CompletedWael Seliem1042015-05-012017-05-31

Narrower conditions

Respiratory Syncytial Virus Infections (3)

Broader conditions

Infections (3)  ·  Mononegavirales Infections (3)  ·  Paramyxoviridae Infections (3)  ·  Pneumovirus Infections (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)

Interventions

Air (1)  ·  MK-1654 (1)  ·  Palivizumab (1)  ·  heliox (1)

Sponsors

Merck Sharp & Dohme LLC (1)  ·  Pfizer (1)  ·  Wael Seliem (1)

Countries

South Africa (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Italy (1)

Results publications

PMID 40602662, PMID 40961423, PMID 42475081